|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 301 - 330 of 367 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Treprostinil Tillomed 1 mg - ml infuusioneste, liuos SPC 2023-06-21
|
PL
|
Resepti
|
Treprostinil Tillomed 10 mg - ml infuusioneste, liuos SPC 2023-06-21
|
PL
|
Resepti
|
Treprostinil Tillomed 2.5 mg - ml infuusioneste, liuos SPC 2023-06-21
|
PL
|
Resepti
|
Treprostinil Tillomed 5 mg - ml infuusioneste, liuos SPC 2023-06-21
|
|
|
European Medicines Agency's website: Trepulmix - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Tresiba - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Trevicopto 40 mikrog - ml silmätipat, liuos, kerta-annospakkaus SPC 2024-07-11
|
PL
|
Resepti
|
Trevicopto Comp 40 mikrog/ml + 5 mg/ml silmätipat, liuos, kerta-annospakkaus SPC 2024-11-06
|
|
|
European Medicines Agency's website: Trevicta - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Trexan 2.5 mg, 10 mg tabletti SPC 2023-02-01
|
PL
|
Resepti
|
Trexan 25 mg_ml injektioneste, liuos, esitäytetty ruisku valmisteyhteenveto 2023-01-17
|
PL
|
Resepti
|
Triaxis injektioneste, suspensio, esitäytetty ruisku SPC 2023-03-27
|
PL
|
Resepti
|
Trica 20 mg-ml injektioneste, suspensio PL 2022-10-10
|
PL
|
Resepti
|
Trica 20 mg-ml injektioneste, suspensio SPC 2022-12-05
|
PL
|
Itsehoito
|
Tricovivax 50 mg-ml liuos iholle SPC 2024-10-31
|
PL
|
Resepti
|
Trientine Tillomed 167 mg kapseli, kova SPC 2023-08-11
|
PL
|
Resepti
|
Trientine Waymade 200 mg kapseli, kova SPC 2023-02-07
|
PL
|
Resepti
|
Triesence 40 mg-ml injektioneste, suspensio SPC 2023-06-21
|
PL
|
Resepti
|
Trikozol 400mg tabletti SPC 2022-11-24
|
PL
|
Resepti
|
Trilaham 5, 25, 50, 100, 200 mg dispergoituva tabletti SPC 2004-06-14
|
PL
|
Resepti
|
Trilandia 5, 25, 50, 100, 200 mg dispergoituva tabletti SPC 2004-06-14
|
PL
|
Resepti
|
Trileptal 150 mg, 300 mg, 600 mg tabletti, kalvopäällysteinen SPC 2024-11-01
|
PL
|
Resepti
|
Trileptal 60 mg-ml oraalisuspensio SPC 2024-11-01
|
|
|
European Medicines Agency's website: Trimbow - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
TRIMETIN 100 mg, 160 mg, 300 mg tabletti SPC 2022-11-01
|
PL
|
Resepti
|
TRIMETIN 100 mg, 160 mg, 300 mg tabletti SPC 2022-11-01
|
PL
|
Resepti
|
Trimopan 10 mg-ml oraalisuspensio SPC 2022-08-30
|
PL
|
Resepti
|
Trimopan 100 mg, 160 mg tabletti, kalvopäällyinen, Trimopan 300 mg tabletti SPC 2022-08-30
|
PL
|
Resepti
|
TrioBe tabletti SPC 2023-09-19
|
PL
|
Resepti
|
Triplixam 5 mg-1.25 mg-5 mg, 5 mg-1.25 mg-10 mg, 10 mg-2.5 mg-5 mg, 10 mg-2.5 mg-10 mg tabletti, kalvopäällysteinen SPC 2023-05-05
|
|
| |